Stay updated with breaking news from Hubert Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Hubert Chen, accomplished drug developer and pharma executive, joins as Chief Medical Officer-- Industry veterans and leading academic experts ...
-- Hubert Chen, accomplished drug developer and pharma executive, joins as Chief Medical Officer
The US Food and Drug Administration (FDA) has granted clearance to Krystal Biotech’s investigational new drug application (IND) for KB408.
15.08.2022 - Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced second quarter 2022 results and provided a business update. “Forte is excited to continue down our new path as ...
Forte Biosciences, Inc. , a biopharmaceutical company focused on autoimmune diseases announces that Dr. Hubert Chen, MD has joined the company as Chief Scientific Officer and President. “Dr.... | June 7, 2022